In an atmosphere of declining research and development (R&D) productivity, mounting pricing pressure and changing regulatory requirements, global pharmaceutical and life sciences companies face increasing challenges to achieve and maintain profitable growth.
Global pharmaceutical outsourcing offers companies an opportunity to face these challenges. By forming strategic relationships with outsourcing partners, companies can focus on core competencies, access specialised expertise, achieve cost-saving benefits and reduce burn rates that lead directly to greater shareholder value.
Over the past two decades, the outsourcing of R&D and manufacturing processes has become increasingly prevalent, and is now a major trend in the pharmaceutical industry. Pharmaceutical companies have moved up the value chain for outsourcing from non-core functions, such as IT and human resources, to secondary core functions. Key drivers behind the trend include:
- Time-to-market
- Cost advantage
- Risk management
- Strategic focus
PricewaterhouseCoopers provides solid, independent insights into identifying, selecting and working with global outsourcing and off-shoring partners.
